• Something wrong with this record ?

Decreased paraoxonase activity in critically ill patients with sepsis

F Novak, L Vavrova, J Kodydkova, F Sr Novak, M Hynkova, A Zak, O Novakova

Language English Country Italy

Document type Research Support, Non-U.S. Gov't

Grant support
NR8943 MZ0 CEP Register

Digital library NLK
Full text - Část
Source

E-resources

NLK ProQuest Central from 2002-05-01 to 2018-12-31
Medline Complete (EBSCOhost) from 2003-05-01 to 1 year ago
Health & Medicine (ProQuest) from 2002-05-01 to 2018-12-31

Paraoxonase 1 is believed to play a role in preventing lipid oxidation and, thus, limiting production of proinflammatory mediators. Systemic inflammatory response in sepsis increases oxidative stress and decreases high-density lipoprotein (HDL) concentrations. The objective of this study was to investigate serum paraoxonase 1 activities in critically ill patients with sepsis and after recovery. Serum paraoxonase 1 arylesterase/paraoxonase activities, concentration of total cholesterol, HDL cholesterol (HDL-C) and serum C-reactive protein (CRP) in septic patients of a medical intensive care unit (n = 30) and age/sex-matched outpatient controls without sepsis (n = 30) were analyzed. Paired convalescent samples were also taken 1 week after recovery (n = 11). In septic patients, both arylesterase (88.3 +/- 36.5 vs. 162.1 +/- 44.8 kU/l, P < 0.001) and paraoxonase (75.2 +/- 50.0 vs. 125.2 +/- 69.4 U/l, P < 0.01) paraoxonase 1 activities decreased as compared to controls. Both activities normalized after recovery. Negative correlation was found between CRP and both arylesterase (r = -0.676, P < 0.001) and paraoxonase (r = -0.401, P < 0.01) as well as positive correlation between HDL-C and both arylesterase (r = 0.585, P < 0.001) and paraoxonase (r = 0.405, P < 0.01) paraoxonase 1 activities. The decreased activity of paraoxonase 1 in negative correlation with CRP offers a potentially useful marker of sepsis progress and recovery in critically ill patients.

000      
03052naa a2200445 a 4500
001      
bmc12008518
003      
CZ-PrNML
005      
20140324132229.0
008      
120316s2010 it eng||
009      
AR
040    __
$a ABA008 $b cze $d ABA008
041    0_
$a eng
044    __
$a it
100    1_
$a Novák, František, $d 1971- $7 mzk2006324218 $u 4th Department of Internal Medicine, 1st Faculty of Medicine, General Teaching Hospital, Charles University in Prague, U Nemocnice 2, CZ-12808, Prague, Czech Republic. fnova@lf1.cuni.cz
245    10
$a Decreased paraoxonase activity in critically ill patients with sepsis / $c F Novak, L Vavrova, J Kodydkova, F Sr Novak, M Hynkova, A Zak, O Novakova
520    9_
$a Paraoxonase 1 is believed to play a role in preventing lipid oxidation and, thus, limiting production of proinflammatory mediators. Systemic inflammatory response in sepsis increases oxidative stress and decreases high-density lipoprotein (HDL) concentrations. The objective of this study was to investigate serum paraoxonase 1 activities in critically ill patients with sepsis and after recovery. Serum paraoxonase 1 arylesterase/paraoxonase activities, concentration of total cholesterol, HDL cholesterol (HDL-C) and serum C-reactive protein (CRP) in septic patients of a medical intensive care unit (n = 30) and age/sex-matched outpatient controls without sepsis (n = 30) were analyzed. Paired convalescent samples were also taken 1 week after recovery (n = 11). In septic patients, both arylesterase (88.3 +/- 36.5 vs. 162.1 +/- 44.8 kU/l, P < 0.001) and paraoxonase (75.2 +/- 50.0 vs. 125.2 +/- 69.4 U/l, P < 0.01) paraoxonase 1 activities decreased as compared to controls. Both activities normalized after recovery. Negative correlation was found between CRP and both arylesterase (r = -0.676, P < 0.001) and paraoxonase (r = -0.401, P < 0.01) as well as positive correlation between HDL-C and both arylesterase (r = 0.585, P < 0.001) and paraoxonase (r = 0.405, P < 0.01) paraoxonase 1 activities. The decreased activity of paraoxonase 1 in negative correlation with CRP offers a potentially useful marker of sepsis progress and recovery in critically ill patients.
590    __
$a bohemika - dle Pubmed
650    02
$a dospělí $7 D000328
650    02
$a senioři $7 D000368
650    02
$a aryldialkylfosfatasa $x krev $7 D043303
650    02
$a biologické markery $7 D015415
650    02
$a C-reaktivní protein $x analýza $7 D002097
650    02
$a cholesterol $x krev $7 D002784
650    02
$a HDL-cholesterol $x krev $7 D008076
650    02
$a kritický stav $7 D016638
650    02
$a ženské pohlaví $7 D005260
650    02
$a lidé $7 D006801
650    02
$a mužské pohlaví $7 D008297
650    02
$a lidé středního věku $7 D008875
650    02
$a sepse $x diagnóza $x patologie $7 D018805
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vávrová, Lucie $7 xx0142642
700    1_
$a Kodydková, Jana $7 xx0142640
700    1_
$a Novák, František, $d 1945- $7 xx0004203
700    1_
$a Hynková, Magdalena
700    1_
$a Žák, Aleš, $d 1951- $7 mzk2007382175
700    1_
$a Nováková, Olga $7 xx0128823
773    0_
$t Clinical & Experimental Medicine $p Clin Exp Med $g Roč. 10, č. 1 (2010), s. 21-25 $w MED00006222 $x 0006-9248
773    0_
$p Clin Exp Med $g 10(1):21-5, 2010 Mar
910    __
$a ABA008 $b x $y 4 $z 0
990    __
$a 20120319124501 $b ABA008
991    __
$a 20140324132301 $b ABA008
999    __
$a ok $b bmc $g 901895 $s 765413
BAS    __
$a 3
BMC    __
$a 2010 $b 10 $c 1 $d 21-25 $m Clinical and Experimental Medicine $x MED00006222
GRA    __
$a NR8943 $p MZ0
LZP    __
$a 2012-1Q10/jj

Find record